Abstract
Biopharmaceutical clinical trials are typically conducted globally with multi-center, multi-regional trials. Meta-analysis is a natural statistical method for combining the data from these trials to increase the reliability of statistical findings. Trials with rare events are not uncommon. This chapter presents an overview of meta-analysis to synthesize summary statistics from multiple clinical trials and then illustrate how to use R software to analyze clinical trials with rare events. we make use of the well-known Rosiglitazone meta-analysis data to illustrate the bias when classical meta-analysis methods are used for rare events and then introduce a R package gmeta for meta-analysis of rare events.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bhaumik, D. K., Amatya, A., Normand, S. T., Greenhouse, J., Kaizar, E., Neelon, B., et al. (2012). Meta-analysis of rare binary adverse event data. Journal of the American Statistical Association, 107(498), 555–567.
Cai, T., Parast, L., & Ryan, L. (2010). Meta-analysis for rare events. Statistics in Medicine, 29(20), 2078–2089.
Chen, D. G., & Peace, K. E. (2013). Applied meta-analysis using R. Chapman & Hall/CRC.
Dahabreh, I. J. (2008). Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone. Clinical Trials, 5, 116–120.
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177–188.
Hardy, R. J., & Thompson, S. G. (1998). Detecting and describing heterogeneity in meta-analysis. Statistics in Medicine, 17, 841–856.
Harwell, M. (1997). An empirical study of hedges homogeneity test. Psychological Methods, 2, 219–231.
Lane, P. W. (2012). Meta-analysis of incidence of rare events. Statistical Methods in Medical Research (2012 Jan 4 Epub).
Nissen, S. E., & Wolski, K. (2007). Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. The New England Journal of Medicine, 356, 2457–2471.
Raudenbush, S. W. and A. S. Bryk (1985). Empirical bayes meta-analysis. Journal of Educational Statistics, 10(2), 75–98.
Shuster, J. J., Jones, L. S., & Salmon, D. A. (2007). Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death. Statistics in Medicine, 26(24), 4375–4385.
Shuster, J. J., & Schatz, D. A. (2008). The rosigliazone meta-analysis: Lessons for the future. Diabetes Care, 31(3) (10 March 2008).
Sutton, A. J., Cooper, N. J., Lambert, P. C., Jones, D. R., Abrams, K. R., & Sweeting, M. J. (2002). Meta-analysis of rare and adverse event data. Expert Review of Pharmacoeconomics and Outcomes Research, 2(4), 367–379.
Sweeting, M. J., Sutton, A. J., & Lambert, P. C. (2004). What to add to nothing? use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine, 23, 1351–1375.
Tian, L., Cai, T., Pfeffer, M., Piankov, N., Cremieux, P., & Wei, L. (2009). Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 by 2 tables with all available data but without artificial continuity correction. Biostatistics, 10(2), 275–281.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Chen, DG., Peace, K.E. (2018). Meta-analysis for Rare Events in Clinical Trials. In: Peace, K., Chen, DG., Menon, S. (eds) Biopharmaceutical Applied Statistics Symposium . ICSA Book Series in Statistics. Springer, Singapore. https://doi.org/10.1007/978-981-10-7826-2_8
Download citation
DOI: https://doi.org/10.1007/978-981-10-7826-2_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7825-5
Online ISBN: 978-981-10-7826-2
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)